Valuation : OrganiGram

Market Cap 207M 150M 129M 122M 111M 14.32B 209M 1.45B 557M 7.26B 562M 550M 23.07B P/E 2026 *
1.82x
P/E 2027 * 18.4x
Enterprise Value 207M 150M 129M 122M 111M 14.32B 209M 1.45B 557M 7.26B 562M 550M 23.07B EV / Sales 2026 *
0.59x
EV / Sales 2027 * 0.45x
Free-Float
68.94%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 2026-01-14
Director of Finance/CFO - 2024-01-07
Chief Operating Officer - 2026-08-18
Director TitleAgeSince
Chairman 65 2018-03-28
Director/Board Member 56 2018-12-16
Director/Board Member 70 2018-12-16
Change 5-day change 1-year change 3-year change Capi.($)
-3.89%+9.83% - - 150M
+0.52%-1.54%+15.00%+171.23% 350M
+0.34%-7.23%-35.59%-41.70% 150M
+1.28%-0.50%+15.12%+102.04% 140M
+5.49%+3.23%-30.43%-62.50% 92.49M
-1.41%-0.49%-40.46%-48.25% 62.82M
Average +0.39%-1.30%-15.27%+24.16% 158.91M
Weighted average by Cap. +0.26%-1.71%-4.19%+74.37%

Financials

2026 *2027 *
Net sales 350M 253M 218M 205M 187M 24.2B 353M 2.45B 941M 12.27B 950M 930M 38.99B 458M 331M 285M 269M 245M 31.69B 462M 3.2B 1.23B 16.08B 1.24B 1.22B 51.06B
Net income 128M 92.85M 79.85M 75.34M 68.64M 8.88B 129M 897M 345M 4.5B 349M 341M 14.3B 8.1M 5.86M 5.04M 4.76M 4.33M 560M 8.17M 56.65M 21.8M 284M 22.01M 21.53M 903M
Net Debt - -
Logo OrganiGram
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!